Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.

about

Appropriate antibiotic management of bacterial lower respiratory tract infections

P2860

Q56942464-63F0CC88-19D4-4306-9E67-93317FCFD54B

P2860

Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.

Item

http://www.wikidata.org/entity/Q54110999

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@en

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@nl

type

Item

label

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@en

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@nl

prefLabel

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@en

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@nl

P1476

Sputum bacteriology and clinic ...... obstructive pulmonary disease.

@en

P2093

Chi Young Jung

http://www.w3.org/2001/XMLSchema#string

Hun Gyu Hwang

http://www.w3.org/2001/XMLSchema#string

Hye Sook Choi

http://www.w3.org/2001/XMLSchema#string

Ji-Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Jusang Kim

http://www.w3.org/2001/XMLSchema#string

Seung Soo Sheen

http://www.w3.org/2001/XMLSchema#string

Sung Ho Yoon

http://www.w3.org/2001/XMLSchema#string

Tae-Hyung Kim

http://www.w3.org/2001/XMLSchema#string

Yong Soo Kwon

http://www.w3.org/2001/XMLSchema#string

P2860

COPD and the microbiome

Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.

Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.

Evaluating the evidence for the implementation of C-reactive protein measurement in adult patients with suspected lower respiratory tract infection in primary care: a systematic review.

Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD.

Recent advances in the rapid diagnosis of respiratory tract infection.

Association between pathogens detected using quantitative polymerase chain reaction with airway inflammation in COPD at stable state and exacerbations.

Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.

Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease.

Zabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial.

P304

1424-1432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CRJ.12671

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seung Won Ra

P577

2017-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28756637

http://www.w3.org/2001/XMLSchema#string

P921

antibiotic

chronic obstructive pulmonary disease

sputum

Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.

about

P2860

P2860

Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921